Warrant [Member]
Class of Warrant or Right [Axis]
Restricted Stock Units [Member]
Award Type [Axis]
Equity Components [Axis]
Stock Option Plan [Member]
Options Granted To Consultants [Member]
2007 Incentive Stock And Awards Plan [Member]
Range One [Member]
Exercise Price Range [Axis]
Options Granted To Employees [Member]
Tranche 4 CEO [Member]
Tranche 5 CEO [Member]
Warrants Issued To Former Major Shareholder [Member]
Related Party [Axis]
Warrants Issued In April 2012 Private Placement [Member]
Underwriter Warrants [Member]
Minimum [Member]
Range [Axis]
Maximum [Member]
Mark Baum [Member]
Title of Individual [Axis]
Range Two [Member]
Range Three [Member]
Range Four [Member]
Range Five [Member]
Tranche 1 CEO [Member]
Tranche 2 CEO [Member]
Tranche 3 CEO [Member]
Consultant Tranche 1 [Member]
Consultant Tranche 2 [Member]
Consultant Tranche 3 [Member]
Consultant Tranche 4 [Member]
Consultant Tranche 5 [Member]
Warrants Issued To Investor Relations Consultant [Member]
Warrants Issued To Investor Relations Consultant [Member]
Restricted Stock Units One [Member]
Warrant [Member]
Customer Relationships [Member]
Finite-Lived Intangible Assets by Major Class [Axis]
Trade Name [Member]
Non-Compete Covenant [Member]
State Pharmacy Licenses [Member]
Restricted Stock [Member]
Class of Stock [Axis]
Pharmacy Creations, LLC [Member]
Legal Entity [Axis]
Period Ending March 31, 2016
Report Date [Axis]
Employees And Directors [Member]
Employees [Member]
Selling And Marketing [Member]
Income Statement Location [Axis]
General And Administrative [Member]
Research And Development [Member]
Directors [Member]
Consultant [Member]
Subsequent Event [Member]
Subsequent Event Type [Axis]
Urigen Pharmaceuticals, Inc [Member]
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Dr. Robert Kammer [Member]
Baum Performance Equity Award [Member]
Monte Carlo Simulation [Member]
Plan Name [Axis]
Monte Carlo Simulation One [Member]
Non-Employee Directors [Member]
Former Directors [Member]
Park Sellers [Member]
Lease Agreement [Member]
Agreement [Axis]
CFO Employment Agreement [Member]
Andrew R. Boll's [Member]
RSU [Member]
CCO Employment Agreement [Member]
John P. Saharek [Member]
Non-Competition Covenant [Member]
Stock Options [Member]
Option Indexed to Issuer's Equity, Type [Axis]
Document And Entity Information
Entity Registrant Name
Entity Central Index Key
Document Type
Document Period End Date
Amendment Flag
Entity Voluntary Filers
Entity Well-KnownSeasoned Issuer
Entity Current Reporting Status
Current Fiscal Year End Date
Entity Filer Category
Entity Public Float
Entity Common Stock, Shares Outstanding
Document Fiscal Period Focus
Document Fiscal Year Focus
Statement of Financial Position [Abstract]
ASSETS
Current assets
Cash and cash equivalents
Restricted short-term investments
Accounts receivable, net
Inventories
Prepaid expenses and other current assets
Total current assets
Intangible assets, net
Goodwill
Furniture and equipment, net
TOTAL ASSETS
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities
Accounts payable and accrued expenses
Accrued payroll and related liabilities
Customer deposits
Current portion of contingent acquisition obligations
Current portion of capital lease obligations
Total current liabilities
Capital lease obligations, net of current portion
Accrued expenses, net of current portion
Contingent acquisition obligations
TOTAL LIABILITIES
Commitments and contingencies
STOCKHOLDERS' EQUITY
Common stock, $0.001 par value, 90,000,000 shares authorized, 9,258,231 and 8,970,364 shares issued and outstanding at December 31, 2014 and 2013, respectively
Additional paid-in capital
Accumulated deficit
TOTAL STOCKHOLDERS' EQUITY
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY
Common stock, par value
Common stock, shares authorized
Common stock, shares issued
Common stock, shares outstanding
Income Statement [Abstract]
Revenues:
Sales, net
License revenues
Total revenues
Cost of sales
Gross profit
Operating expenses:
Selling and marketing
General and administrative
Research and development
Total operating expenses
Loss from operations
Other income (expense):
Interest expense
Interest income
Total other income, net
Net loss
Basic and diluted net loss per share of common stock
Weighted average number of shares of common stock outstanding, basic and diluted
Statement [Table]
Statement [Line Items]
Balance
Balance, share
Exercise of stock options, net of tax withholding
Exercise of stock options, net of tax withholding, shares
Stock-based compensation
Issuance of common stock related to consulting agreements
Issuance of common stock related to consulting agreements, shares
Exercise of stock options
Exercise of stock options, shares
Cancelled common stock at $5.25 per share related to reverse stock split, February 2013
Cancelled common stock at $5.25 per share related to reverse stock split, February 2013, shares
Public offering of common stock at $5.25 per share, net of costs of $596,281, in February and March 2013
Public offering of common stock at $5.25 per share, net of costs of $596,281, in February and March 2013, shares
Issuance of common stock upon vesting of RSUs net of tax withholding
Issuance of common stock upon vesting of RSUs net of tax withholding , shares
Exercise of warrants
Exercise of warrants , shares
Issuance of common stock upon vesting of RSUs
Issuance of common stock upon vesting of RSUs, shares
Stock-based compensation
Stock-based compensation, shares
Common stock issued in settlement of contract dispute
Common stock issued in settlement of contract dispute, shares
Net loss
Balance
Balance, share
Statement of Stockholders' Equity [Abstract]
Issuance of common stock for public offering price per share
Cancelled common stock price per share
Statement of Cash Flows [Abstract]
CASH FLOWS FROM OPERATING ACTIVITIES
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization of furniture and equipment
Amortization of intangible assets
Stock-based compensation and payments
Changes in assets and liabilities, net of effects from acquisitions:
Accounts receivable
Inventories
Prepaid expenses and other current assets
Accounts payable and accrued expenses
Accrued payroll and related liabilities
Customer deposits
NET CASH USED IN OPERATING ACTIVITIES
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of restricted short-term investments
Purchase of Pharmacy Creations, LLC, net of cash and advances
Purchases of furniture and equipment
NET CASH USED IN INVESTING ACTIVITIES
CASH FLOWS FROM FINANCING ACTIVITIES
Cancelled common stock
Payments on capital lease obligations
Net proceeds from exercise of warrants and stock options
Proceeds from issuance of common stock and warrants for cash, net of offering costs
NET CASH PROVIDED BY FINANCING ACTIVITIES
NET CHANGE IN CASH AND CASH EQUIVALENTS
CASH AND CASH EQUIVALENTS, beginning of period
CASH AND CASH EQUIVALENTS, end of period
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid for income taxes
Cash paid for interest
SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Issuance of and adjustment to common stock and warrants to consulting firms for prepaid consulting fees
Reclassification of deferred offering costs in connection with equity offering
Issuance of common stock for consulting services included in accounts payable and accrued expenses
Purchase of furniture and equipment with a capital lease
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization
Accounting Policies [Abstract]
Summary of Significant Accounting Policies
Business Combinations [Abstract]
Acquisition - Pharmacy Creations, LLC
Restricted Short-term Investment
Restricted Short-Term Investment
Inventory Disclosure [Abstract]
Inventories
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Prepaid Expenses and Other Current Assets
Property, Plant and Equipment [Abstract]
Furniture and Equipment
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets and Goodwill
Payables and Accruals [Abstract]
Accounts Payable and Accrued Expenses
Debt Disclosure [Abstract]
Debt
Equity [Abstract]
Stockholders' Equity
Income Tax Disclosure [Abstract]
Income Taxes
Compensation and Retirement Disclosure [Abstract]
Employee Savings Plan
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies
Segment Reporting [Abstract]
Segment Information
Subsequent Events [Abstract]
Subsequent Events
Basis of Presentation
Business Combinations
Research and Development
Intellectual Property
Revenue Recognition and Deferred Revenue
Cost of Sales
Income Taxes
Cash and Cash Equivalents
Concentrations of Credit Risk
Accounts Receivable
Inventories
Furniture and Equipment
Goodwill and Intangible Assets
Impairment of Long-Lived Assets
Deferred Rent
Fair Value Measurements
Stock-Based Compensation
Basic and Diluted Net Loss per Common Share
Use of Estimates
Reclassifications
Recently Adopted Accounting Pronouncements
Recently Issued Accounting Pronouncements
Schedule of Basic and Diluted Earnings Per Common Share
Schedule of Acquisition Date Fair Value of Consideration
Schedule of Estimated Fair Value of Assets Acquired and Liabilities Assumed
Schedule of Result of Operation from Acquisition
Schedule of Pro Forma Financial Information
Schedule of Intangible Assets Acquisition
Schedule of Inventories
Schedule of Prepaid Expenses and Other Current Assets
Schedule of Furniture and Equipment
Schedule of Intangible Assets
Schedule of Amortization Expenses for Intangible Assets
Schedule of Estimated Future Amortization Expense
Schedule of Changes in Carrying Value of Goodwill
Schedule of Accounts Payable and Accrued Expenses
Schedule of Stock Option Plan Activity
Schedule of Fair Value Assumption
Schedule of Shares Outstanding and Exercisable
Market-based Vesting Conditions for Restricted Stock Units Granted
Schedule of Restricted Stock Units Activity
Schedule of Warrants Activity
Schedule of Warrants Outstanding and Warrants Exercisable
Schedule of Stock Based Compensation Granted to Employees Directors Consultants
Schedule of Provision for Income Taxes
Schedule of Income Tax Reconciliation
Schedule of Deferred Tax Assets and Liabilities
Schedule of Lease Equipment Under Capital Lease
Schedule of Future Payments Under Leases
Deposit coverage limits by FDIC, per owner
Cash deposits in excess of FDIC limits
Accounts receivable, net of allowance for doubtful accounts
furniture and equipment depreciated useful life
Impairment of long-lived assets
Common stock equivalents, dilutive instruments
Number of restricted stock included in common stock equivalents
Numerator - net loss
Denominator - weighted average number of shares outstanding, basic and diluted
Net loss per share, basic and diluted
Cash paid for business acquisition
Contingent cash payment
Expected revenue
Expected revenue date
Maximum number of common stock applied for contingent stock payment
Condition for contingent stock payment
Business acquisition, total fair value transferred
Business combination purchase price allocation for good will
Fair value of liability for estimated acquisition
Cash payment to the PC Sellers at closing
Contingent common stock issuance to the PC Sellers
Contingent cash consideration to the PC Sellers
Total acquisition date fair value
Cash and cash equivalents
Accounts receivable
Prepaid expenses and other assets
Inventory
Property and equipment
Intangible assets
Total identifiable assets acquired
Accounts payable and accrued liabilities
Other liabilities
Total liabilities assumed
Total identifiable assets less liabilities assumed
Net assets acquired
Total revenues
Operating loss
Total revenues
Net loss
Fair Value
Useful Life
Restricted Short-term Investment Details Narrative
Certificate of deposit
Raw materials
Work in progress
Finished goods
Total inventories
Prepaid stock-based consulting expenses
Prepaid rent
Prepaid insurance
Other prepaid expenses and deposits
Total prepaid expenses and other current assets
Computer software and hardware
Furniture and equipment
Lab and pharmacy equipment
Leasehold improvements
Furniture and equipment, gross
Accumulated depreciation and amortization
Furniture and equipment, Net
Amortization periods (in years)
Cost
Accumulated amortization
Net Carrying value
2015
2016
2017
2018
2019
Thereafter
Intangible assets
Goodwill, Beginning
PC Acquisition
Goodwill, Ending
Area of office space
Area of previous office space
Recognized lease losses related to estimated remaining lease liability
Stock based compensation accrual
Stock-based compensation expense related to restricted common stock issuances and accruals
Accounts payable
Deferred rent
Building lease liability(1)
Other accrued expenses
Total accounts payable and accrued expenses
Less: Current portion
Non-current total accounts payable and accrued expenses
Line of credits borrowing limit maximum
Borrowed term loan
Capital stock, shares authorized
Number of underwritten public offering common stock shares closed
Common stock price per share
Proceeds from public offerings
Additional shares purchased by underwriters
Net cash proceeds from the exercise of the over-allotment option
Stock issued during period value issued to underwriters
Underwriting agreement description
Payment made on cancellation of common stock
Payment made on cancellation of common stock, shares
Number of shares issued for related party vesting of RSUs
Common stock shares issued for services
Common stock issued for services
Common stock issued settle cashless exercise provision, shares
Common stock issued shares
Common stock issued shares value
Shares issued upon exercise of stock options, shares
Shares issued upon exercise of stock options
Additional shares issued upon exercise of stock options, shares
Stock option purchase of exercise price
Proceeds from issuance of common stock
Exercise of common stock option to purchase of common stock
Common stock exercise price per share
Number of common stock held for payroll tax
Shares issued upon warrants exercise
Shares issued upon exercise of warrant
Warrants and shares issued upon excise of common stock
Warrants to purchase common stock exercise price per share
Proceeds from issuance of warrants
Number of warrants shares issued
Exercise of warrant to purchase of common stock
Warrants shares exercise price per share
Preferred stock, shares authorized
Preferred stock, par value
Preferred stock, shares issued
Preferred stock, shares outstanding
Maximum number of common stock issuance under the plan
Number of future issuances share under the plan
Stock option exercise price
Intrinsic value of stock options exercised
Contractual term of stock options granted
Stock options granted vesting terms
Percentage of forfeiture factor
Unrecognized compensation expense related to unvested stock options granted under the Plan
Expense expected to recognize over the weighted-average remaining vesting period
Restricted stock units issued
Restricted stock vest in future
Target ranging price
Restricted stock vested immediately
Granted restricted stock units per person
Granted restricted stock units
Number of granted restricted stock units unvested agreed to cancel
Fair value of restricted stock units
Fair value of canceled restricted stock units plus incremental cost, shares
Issuance of restricted stock units, shares
Fair value assumptions, life term
Fair value assumptions, volatility
Fair value assumptions, risk free interest rate
Initial fair value of restricted stock units, shares
Percentage of restricted stock units vested
Percentage of remaining restricted stock units vested
Fair value assumption of volatility, minimum
Fair value assumption of volatility, maximum
Fair value assumption of risk free interest rates, minimum
Fair value assumption of risk free interest rates, maximum
Issuance of restricted stock units were forfeited and deemed, shares
Restricted stock units vest period
Number of director resigned and forfeited
Stock based compensation
Warrant issued to purchase number of common stock
Warrants exercise price
Warrants expire
Number of warrants vested immeditely
Number of shares vested in installments for each five months
Fair value of warrants
Stock based compensation of warrants issued
Number of shares, Outstanding, Beginning balance
Number of shares, Options granted
Number of shares, Options exercised
Number of shares, Options cancelled/forfeit
Number of shares, Outstanding, Ending balance
Number of shares, Options exercisable
Number of shares, Options vested and expected to vest
Weighted Avg. Exercise Price, Outstanding, Beginning balance
Weighted Avg. Exercise Price, Options granted
Weighted Avg. Exercise Price, Options exercised
Weighted Avg. Exercise Price, Options cancelled/forfeit
Weighted Avg. Exercise Price, Outstanding, Ending balance
Weighted Avg. Exercise Price, Exercisable Ending Balance
Weighted Avg. Exercise Price, Vested and expected to vest - end of period
Weighted Avg. Remaining Contractual Life, Options outstanding
Weighted Avg. Remaining Contractual Life, Options exercisable
Weighted Avg. Remaining Contractual Life, Options vested and expected to vest
Aggregate Intrinsic Value, Options outstanding
Aggregate Intrinsic Value, Options exercisable
Aggregate Intrinsic Value, Options vested and expected to vest
Weighted-average fair value of options granted
Expected terms (in years)
Expected volatility, minimum
Expected volatility, maximum
Risk-free interest rate, minimum
Risk-free interest rate, maximum
Dividend yield
Range of Exercise Prices, minimum
Range of Exercise Prices, maximum
Number of Options Outstanding
Weighted Average Remaining Contractual Life in Years
Weighted Average Exercise Price
Number Exercisable
Weighted Average Exercisable Exercise Price
Percentage of Number of Shares Granted
Number of Shares
Target Share Price
Number of RSUs, Outstanding, Beginning balance
Number of RSUs granted
Number of RSUs vested
Number of RSUs cancelled/forfeit
Number of RSUs, Outstanding, Ending balance
Weighted Average Grant Date Fair Value, Beginning balance
Weighted Average Grant Date Fair Value, RSUs granted
Weighted Average Grant Date Fair Value, RSUs vested
Weighted Average Grant Date Fair Value, RSUs cancelled/forfeit
Weighted Average Grant Date Fair Value, Ending balance
Number of shares, Outstanding, Beginning balance
Number of Shares Subject to Warrants Outstanding, Granted
Number of Shares Subject to Warrants Outstanding, Exercised
Number of Shares Subject to Warrants Outstanding, Expired
Number of shares, Outstanding, Ending balance
Weighted Average Remaining Contractual Life Of The Outstanding Warrants In Years
Weighted Avg. Exercise Price, Outstanding, Beginning balance
Weighted Avg. Exercise Price, Granted
Weighted Avg. Exercise Price, Exercised
Weighted Avg. Exercise Price, Expired
Weighted Avg. Exercise Price, Outstanding, Ending balance
Issue Date
Warrants Outstanding
Exercise Price
Warrants Exercisable
Expiration Date
Stock based compensation related to equity instruments granted to related parties
Deferred tax asset valuation allowance
Federal net operating loss carryforwards
Federal net operating loss expiration date
Federal research and development tax credits
Federal research and development tax credits expiration date
State net operating loss carryforwards
State net operating loss expiration date
State research and development tax credits
Deferrerd tax asset
Deferrerd tax asset excess tax benefits
Federal
State
Total current
Federal
State
Change in valuation allowance
Total deferred
Income tax provision (benefit)
U.S. federal statutory tax rate
Benefit of lower tax brackets
State tax benefit, net
Research and development credits
Employee stock based compensation
Loss on debt conversion
Other
Valuation allowance
Effective income tax rate
NOL's
Depreciation and amortization
Other
Research & development credits
Deferred stock compensation
Unrealized gain or loss on investments
Total deferred tax assets
Valuation allowance
Net deferred tax assets
Percentage of salary deposits in tax deferred investment account
Percentage of contributions made by the company
Contributions by the company
Leases equipment under capital lease with interest rate
Equipment under capital leases net
Related accumulated depreciation
Lease agreement for office space (Square feet)
Operating lease Expiry
Operating lease, monthly rental
Operating lease, rent increase percentage
Rent expense
License agreement commitments description
Minimum royalties to be paid each calendar year
Value of product development investment
Royalties range percentage
Maximum aggregate value of cash fees
2015
2016
Total minimum lease payments
Less amount representing interest
Present value of future minimum lease payments
Less current portion
Capital lease obligation, net of current portion
2015
2016
2017
2018
2019
Thereafter
Total
Maximum percentage of sales derived from single customer
Percentage of drug and chemical purchases from three main suppliers
Consultant Tranche 1 [Axis]
Shares issued upon exercise of warrants, shares
Warrants shares exercise price per share
Stock issued during period resticted common stock issued, shares
Aggregate cash purchase price
Common stock issued shares
Common stock value based on average closing price
Quarterly cash payments for acquisition
Amount of closing price, total
Aggregated amount of closing price
Issuance of common stock for each payment
Number of square feets of lab and office
Rent amount
Percentage of annual rent increases
Expiration of lease term
Employment agreement term
Annual base salary
Percentage of current annual salary
Percentage of target current annual salary
Term of stock option
Acquisition Of Related Party Goodwill.
Aggregate Value Of Cash Fees
Aggregated Amount Of Closing Price.
Agreement [Axis]
Amount Of Closing Price.
Andrew .R Bolls [Member]
Area Of Square Feet.
Average Closing Price Of Common Stock.
Baum Performance Equity Award [Member]
Building Lease Liability.
Business Acquisition Contingent Acquired Obligations Liabilities.
Business Acquisition Purchase Price Allocation Goodwill.
CCO Employment Agreement [Member]
CFO Employment Agreement [Member]
Cancellation Of Restricted Stock Units During Period
Cancelled Common Stock Price Per Share.
Cancelled Common Stock Shares Related To Reverse Stock Split February 2013 Shares.
Cancelled Common Stock Shares Related To Reverse Stock Split February 2013.
Common Stock Equivalents Dilutive Instruments.
Common stock exercise price per share.
Common stock issued settle cash less exercise provision shares.
Consultant
Consultant Tranche Five [Member]
Consultant Tranche Four [Member]
Consultant Tranche One [Member]
Consultant Tranche Three [Member]
Consultant Tranche Two [Member]
Contingent cash consideration to the relatedparty.
Contingent common stock issuance to the Sellers.
Deferred Income Change In Valuation Allowance.
Deferred Tax Asset Tax Credit carry Forwards Depreciation And Amortization.
Deferred Tax Assets Tax Acquired Net Operating Loss And Credit Carry Forwards.
Percentage of contributions made by the company.
Dr Robert Kammer [Member]
Effecticve Income Tax Rate Benefit Of Lower Tax Brackets.
Effective Income Tax Rate Loss On Debt Conversion.
Employees And Directors [Member]
Employees [Member]
Employment Agreement Term.
Tranche 4 CEO
Tranche 5 CEO
Executive Restricted Stock Units Tranche One [Member]
Executive Restricted Stock Units Tranche Three [Member]
Executive Restricted Stock Units Tranche Two [Member]
Exercise of common stock option to purchase of common stock.
Exercise of warrant to purchase of common stock.
Expected revenue date.
Expected revenue.
Fair value of canceled restricted stock units plus incremental cost shares.
Fair Value Of Warrants.
Federal net operating loss expiration date.
Federal Research And Development Tax Credits.
Federal Research And Development Tax Credits Expiration Date.
Former Directors [Member]
General And Administrative [Member]
Initial fair value of restricted stock units shares.
Issuance Of And Adjustment To Common Stock And Warrants To Consulting Firms For Prepaid Consulting Fees.
Issuance Of Common Stock And Stock Options Shares Related To Consulting Agreements Shares One.
Issuance Of Common Stock And Stock Options Value Related To Consulting Agreements One.
Issuance of common stock for public offering price per share.
Issuance Of Common Stock Upon Vesting Of Rsus Net Of Tax Withholding.
Issuance Of Common Stock Upon Vesting Of Rsus Net Of Tax Withholding Shares.
Issuance Of Common Stock Upon Vesting Of Rsus Shares.
John .P Saharek [Member]
Lab And Pharmacy Equipment Gross.
Lease Agreement [Member]
Leases Equipment Under Capital Lease With Interest Rate.
License agreement commitments description.
Mark Baum [Member]
Maximum deposit coverage limits.
Monte Carlo Simulation [Member]
Monte Carlo Simulation One [Member]
Non Employee Directors [Member]
Number Exercisable
Number of common stock held for payroll tax.
Number of director resigned and forfeited.
Number of future issuances share under the plan.
Number Of Shares Applied For Contigent Stock Payment.
Number Of Shares Tied To Target.
Number of Shares Vested in Installments.
Number of underwritten public offering common stock shares closed.
Number of warrants shares issued.
Number of warrants vested immeditely.
Options granted to employees
Options exercise price.
Options granted to consultants
Park Sellers [Member]
Payment Of Cash To Contigent.
Percentage Of Current Annual Salary.
Percentage of drug and chemical purchases from three main suppliers.
Percentage of forfeiture factor.
Percentage Of Increases Current Annual Salary.
Percentage of remaining restricted stock units vested.
Percentage of restricted stock units vested.
Percentage of salary deposits in tax deferred investment account.
Percentage Shares Tied To Target Of Number Of Shares Granted.
Period Ending March 31, 2016 [Member]
Pharmacy Creations Llc [Member].
Prepaid Stock based Consulting Expenses.
Previous Office Space Area.
Purchase Of Furniture And Equipment With Capital Lease.
Quarterly Cash Payments.
RSU Member.
Range five [member]
Range four [member].
Range one [member].
Range three [member].
Range two [member].
Recently Announced Accounting Pronouncements [PolicyTextBlock].
Reclassification Of Deferred Offering CostsIn Connectionwit Equity Offering
Recognized lease losses related to estimated remaining lease liability.
Research And Development [Member]
Number of restricted stock included in common stock equivalents.
Restricted Stock Units Granted During Period Per Person
Restricted Stock Units RSU One [Member].
Restricted Stock Vest In Future.
Restricted Stock Vested Immediately.
Royalties Range Percentage
Schedule Of Marketbased Vesting Conditions Further [Table Text Block]
Schedule Of Prepaid Expenses And Other Current Assets [TableTextBlock].
Schedule of Result of Operation from Acquisition [Table Text Block].
Schedule of warrants outstanding and exercisable [Table Text Block]
Selling And Marketing [Member]
Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price
Warrants Outstanding
Exercise Price
Vested
Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercises In Period Weighted Average Exercise Price
Share Based Compensation Arrangements By Share Based Payment Award Non Options Expirations In Period Weighted Average Exercise Price
Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price
Weighted Average Exercisable Exercise Price
Warrants Exercisable
Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Exercisable Weighted Average Remaining Contractual Term
Share based Compensation Arrangement By Share based Payment Award Options Granted Weighted Average Remaining Contractual Term1.
State net operating loss expiration date.
State Research And Development Tax Credits.
Stock Issued During Period For Exercise Of Warrants.
Stock Issued During Period Shares For Exercise Of Warrants.
Stock Issued During Period Shares For Public Offering.
Stock issued during period shares issued to underwriters.
Stock Issued During Period Shares Stock Options Exercised Four.
Stock Issued During Period Shares Stock Options Exercised One.
Stock Issued During Period Shares Warrants Exercised.
Stock Issued During Period Value For Public Offering.
Stock issued during period value issued to underwriters.
Stock Issued During Period Value Stock Options Exercised Four.
StockOptionPlanMember
Stock Options Granted Vesting Terms Description.
Stock Shares Issued Duing Period For Settlement Of Contract Dispute.
Stock Shares Issued Duing Period Shares For Settlement Of Contract Dispute.
Shares issued upon exercise of warrant.
Target Ranging Price
Target Share Price
Term Of Stock Option.
2007 Incentive Stock And Awards Plan [Member]
Underwriter Warrants [Member].
Underwriting Agreement Description
Urigen Pharmaceuticals Inc [Member]
Value of product development investment.
Warrant
Warrants and shares issued upon excise of common stock.
Warrants Exercise Price Per Share.
Warrants Expiration Date.
Warrants Expired Duration
Warrants Issuance Date.
Warrants Issued In April Two Thousand Twelve Private Placement [Member]
Warrants Issued To Former Major Shareholder [Member]
Warrants Issued To Investor Relations Consultant One [Member]
Warrants Issued To Investor Relations Consultant Two [Member]
Warrants shares exercise price per share.
Warrants to purchase common stock exercise price per share.
Percentage of annual rent increases.
Non Competition Covenant [Member]
WarrantsIssuedToInvestorRelationsConsultantTwoMember
WarrantActivityMember
Assets, Current
Assets
Liabilities, Current
Liabilities
Stockholders' Equity Attributable to Parent
Liabilities and Equity
Revenue, Net
Health Care Organization, Medical Supplies and Drugs Expense
Gross Profit
Operating Costs and Expenses
Operating Income (Loss)
Interest Expense
Nonoperating Income (Expense)
Shares, Outstanding
Increase (Decrease) in Accounts Receivable
Increase (Decrease) in Inventories
Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Accounts Payable and Accrued Liabilities
Increase (Decrease) in Employee Related Liabilities
Increase (Decrease) in Customer Deposits
Net Cash Provided by (Used in) Operating Activities
Payments to Acquire Short-term Investments
Payments to Acquire Property, Plant, and Equipment
Net Cash Provided by (Used in) Investing Activities
Payments for Repurchase of Common Stock
Repayments of Debt and Capital Lease Obligations
Net Cash Provided by (Used in) Financing Activities
Cash and Cash Equivalents, Period Increase (Decrease)
Inventory Disclosure [Text Block]
Income Tax, Policy [Policy Text Block]
Inventory, Policy [Policy Text Block]
Property, Plant and Equipment, Policy [Policy Text Block]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net
Business Acquisition, Pro Forma Revenue
Business Acquisition, Pro Forma Net Income (Loss)
Property, Plant and Equipment, Gross
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
Accounts Payable and Accrued Liabilities
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice
Current Income Tax Expense (Benefit)
Deferred Federal Income Tax Expense (Benefit)
Deferred State and Local Income Tax Expense (Benefit)
Deferred Income Tax Expense (Benefit)
Income Tax Expense (Benefit)
Deferred Tax Assets, Tax Credit Carryforwards, Other
Deferred Tax Assets, Gross
Deferred Tax Assets, Valuation Allowance
Deferred Tax Assets, Net of Valuation Allowance
Capital Leases, Future Minimum Payments Due, Next Twelve Months
Capital Leases, Future Minimum Payments Due in Two Years
Capital Leases, Future Minimum Payments Due
Capital Leases, Future Minimum Payments, Interest Included in Payments
Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments
Operating Leases, Future Minimum Payments, Next Rolling Twelve Months
Operating Leases, Future Minimum Payments, Due in Rolling Year Two
Operating Leases, Future Minimum Payments, Due in Rolling Year Three
Operating Leases, Future Minimum Payments, Due in Rolling Year Four
Operating Leases, Future Minimum Payments, Due in Rolling Year Five
Operating Leases, Future Minimum Payments, Due in Rolling after Year Five
Operating Leases, Future Minimum Payments Due
Class of Warrant or Right, Exercise Price of Warrants or Rights